Phosphatidylinositol 3-kinase a–selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors: Results from the first-in-human study

Dejan Juric, Jordi Rodon, Josep Tabernero, Filip Janku, Howard A. Burris, Jan H.M. Schellens, Mark R. Middleton, Jordan Berlin, Martin Schuler, Gil Martin Marta, Hope S. Rugo, Seggewiss Bernhardt Ruth, Alan Huang, Douglas Bootle, David Demanse, Lars Blumenstein, Christina Coughlin, Cornelia Quadt, José Baselga

Research output: Contribution to journalArticleResearchpeer-review

146 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phosphatidylinositol 3-kinase a–selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors: Results from the first-in-human study'. Together they form a unique fingerprint.

Medicine & Life Sciences